Details of the Drug

General Information of Drug (ID: DM2IEB7)

Drug Name
Anti-CD30-CAR T cells
Indication
Disease Entry ICD 11 Status REF
Hodgkin lymphoma 2B30 Phase 1 [1]
Large cell lymphoma 2A80.Z Phase 1 [1]
Lymphoma 2A80-2A86 Phase 1 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0TC6X
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lymphocyte activation antigen CD30 (TNFRSF8) TT2GM5R TNR8_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03049449) T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas